Weekly Postings
See something of interest? Please share our postings with colleagues in your institutions! Spotlight Deadline Extended! Apply by November 23 to participate in the 2019 Critical Appraisal Institute for Librarians! – Craving more confidence in leading EBM sessions for medical students? Puzzled on how to guide students about study design and in depth critical appraisal? Frustrated with statistics? This six week online program will develop librarian’s critical appraisal skills via enhanced understanding of research design, biomedical statistics, and clinical reasoning to apply knowledge in teaching target populatio...
Source: NN/LM Middle Atlantic Region Blog - November 16, 2018 Category: Databases & Libraries Authors: Hannah Sinemus Tags: Weekly Postings Source Type: news

What to Know About Getting a Flu Shot This Year, No Matter Who ’ s Paying
Flu season is here, and there are at least six types of vaccine to choose from. It ’ s worth studying the options to determine which is likely to protect you the most. (Source: NYT Health)
Source: NYT Health - November 15, 2018 Category: Consumer Health News Authors: TARA SIEGEL BERNARD Tags: Vaccination and Immunization Influenza Health Insurance and Managed Care Children and Childhood Viruses Patient Protection and Affordable Care Act (2010) Deaths (Fatalities) Personal Finances Elderly Source Type: news

FluChip-8G tested in US and China for rapid characterization of influenza viruses
(InDevR, Inc.) Scientists at Duke Kunshan University and Duke University are collaborating with InDevR Inc. to evaluate the FluChip-8G Insight system for the rapid identification of the influenza virus subtype from human and animal samples. (Source: EurekAlert! - Infectious and Emerging Diseases)
Source: EurekAlert! - Infectious and Emerging Diseases - November 15, 2018 Category: Infectious Diseases Source Type: news

100 Years of Pandemic Influenza Preparedness 100 Years of Pandemic Influenza Preparedness
This paper highlights advances in medical care and progress in preparedness and countermeasures since the 1918 influenza pandemic. What remains to be done to improve readiness for the next pandemic?American Journal of Public Health (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - November 13, 2018 Category: Consumer Health News Tags: Infectious Diseases Journal Article Source Type: news

Ask Well: Would Two Flu Shots Protect Me Better Than One?
Booster doses can make the flu vaccine more effective, but the benefit is limited to a few specific groups. (Source: NYT Health)
Source: NYT Health - November 9, 2018 Category: Consumer Health News Authors: RICHARD KLASCO, M.D. Tags: Vaccination and Immunization Influenza Source Type: news

Antibiotic-Resistant Infections Doubled Since 2007 in Europe Antibiotic-Resistant Infections Doubled Since 2007 in Europe
The burden from antibiotic-resistant bacterial infections in Europe has doubled since 2007 and is now similar to the combined burden of influenza, tuberculosis, and HIV, a study found.Medscape Medical News (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - November 8, 2018 Category: Consumer Health News Tags: Infectious Diseases News Source Type: news

The Critical Role EMS Plays in Fighting the Flu
Influenza has been impacting public health on a global scale since the beginning of recorded history. Influenza, also known as the “flu,” has numerous organizations committed to public health research, developing vaccines, and educating best practices preparing for the upcoming flu season. By gaining an understanding of the flu through history, virology, and how it impacts our society, we can have a better appreciation for the commitment that’s involved with combating the flu. What Is Influenza (and What’s Not)? The eyes of an epidemiologist can twitch for a variety of reasons, one of them being whe...
Source: JEMS Operations - November 8, 2018 Category: Emergency Medicine Authors: Morgan K. Anderson, MPH Tags: Exclusive Articles Operations Source Type: news

InDevR's VaxArray platform to tackle measles-Rubella vaccines
(InDevR, Inc.) InDevR announced today that it will pursue proof of concept development for new VaxArray potency assays for measles (M) and rubella vaccines sponsored by the Bill& Melinda Gates Foundation. The long-term objective is to create in vitro measles and rubella potency assays in order to deliver high quality MR vaccines to market faster and with lower production costs. The project will leverage the multiplexed VaxArray platform, which was first developed and validated for more efficient potency testing of influenza vaccines. (Source: EurekAlert! - Infectious and Emerging Diseases)
Source: EurekAlert! - Infectious and Emerging Diseases - November 8, 2018 Category: Infectious Diseases Source Type: news

Mark your calendar: All infectious diseases are seasonal
(Columbia University's Mailman School of Public Health) Most of us are aware of the seasonal cycle of influenza outbreaks, which for Americans peak in the winter. In a new paper, Micaela Martinez, Ph.D., a scientist at the Columbia Mailman School of Public Health, makes a case that all infectious diseases have a seasonal element. The 'Pearl' article appears in the journal PLOS Pathogens. (Source: EurekAlert! - Infectious and Emerging Diseases)
Source: EurekAlert! - Infectious and Emerging Diseases - November 8, 2018 Category: Infectious Diseases Source Type: news

An autoimmune disease variant of IgG1 modulates B cell activation and differentiation
The maintenance of autoreactive B cells in a quiescent state is crucial for preventing autoimmunity. Here we identify a variant of human immunoglobulin G1 (IgG1) with a Gly396->Arg substitution (hIgG1-G396R), which positively correlates with systemic lupus erythematosus. In induced lupus models, murine homolog Gly390->Arg (G390R) knockin mice generate excessive numbers of plasma cells, leading to a burst of broad-spectrum autoantibodies. This enhanced production of antibodies is also observed in hapten-immunized G390R mice, as well as in influenza-vaccinated human G396R homozygous carriers. This variant potentiates t...
Source: ScienceNOW - November 8, 2018 Category: Science Authors: Chen, X., Sun, X., Yang, W., Yang, B., Zhao, X., Chen, S., He, L., Chen, H., Yang, C., Xiao, L., Chang, Z., Guo, J., He, J., Zhang, F., Zheng, F., Hu, Z., Yang, Z., Lou, J., Zheng, W., Qi, H., Xu, C., Zhang, H., Shan, H., Zhou, X.-j., Wang, Q., Shi, Y., L Tags: Immunology, Medicine, Diseases reports Source Type: news

Cocoa found to have a powerful inhibitory effect on influenza virus infections
(Natural News) Cocoa can protect against an influenza infection by activating the body’s natural immunity and enhancing immune response, according to a study in the Journal of the Science of Food and Agriculture. The study, conducted by researchers in Japan, looked the protective effect of cocoa on the influenza virus using both laboratory testing and... (Source: NaturalNews.com)
Source: NaturalNews.com - November 7, 2018 Category: Consumer Health News Source Type: news

CDC Provides Influenza Updates, New Clinician Resources
The CDC recently issued an update on the current flu season and published resources to help clinicians make a strong recommendation that their patients receive the flu vaccine. (Source: AAFP News)
Source: AAFP News - November 7, 2018 Category: Primary Care Source Type: news

Cocoa provides strong protection against the influenza virus
(Natural News) Researchers in Japan found that cocoa can provide strong protection against the influenza virus. In the study published in the Journal of the Science of Food and Agriculture, the researchers examined the protective effect of cocoa on the influenza virus using both laboratory testing and clinical trials. Cocoa has been known to contain... (Source: NaturalNews.com)
Source: NaturalNews.com - November 7, 2018 Category: Consumer Health News Source Type: news

Personal Health: Need a Flu Shot? Get It Now
Immunity tends to wane by 20 percent a month, leaving those who got their shot in August or September with less than desirable protection by the time they ’ re exposed. (Source: NYT Health)
Source: NYT Health - November 5, 2018 Category: Consumer Health News Authors: JANE E. BRODY Tags: Influenza Vaccination and Immunization Tamiflu (Drug) Relenza (Drug) Viruses Epidemics Source Type: news

Tethered antibodies present a potential new approach to prevent influenza virus infections
(Scripps Research Institute) As co-leaders of an international collaboration, scientists at Scripps Research have discovered that tethering four antibodies together may be an effective strategy for neutralizing all types of influenza virus known to infect humans. (Source: EurekAlert! - Infectious and Emerging Diseases)
Source: EurekAlert! - Infectious and Emerging Diseases - November 5, 2018 Category: Infectious Diseases Source Type: news

The frontlines of influenza research
(Human Vaccines Project) On the centennial of the 1918 influenza pandemic, join us for a scientific summit on cutting-edge influenza and human immune system research. Held Nov. 15-16 in Nashville, TN, the summit will include a special press briefing, featuring some of the latest work on universal flu vaccines. (Source: EurekAlert! - Infectious and Emerging Diseases)
Source: EurekAlert! - Infectious and Emerging Diseases - November 5, 2018 Category: Infectious Diseases Source Type: news

What is the Dutch Protocol for Gender Dysphoria?
Discussion Terminology related to gender∂has changed over time and with newer more specific terminology developing more consensus. Also terminology used by patients to describe themselves or their situation may be different than below. “Gender – denotes the public (and usually legally recognized) lived role as boy or girl, man or woman. Biological factors combined with social and psychological factors contribute to gender development.” Gender is not dichotomous and other terms such as third gender, agender or gender queer reflect this. “Assigned gender – refers to a person’s initi...
Source: PediatricEducation.org - November 5, 2018 Category: Pediatrics Authors: pediatriceducationmin Tags: Uncategorized Source Type: news

Molecular virologist fights influenza at the molecular level
(University of Alabama at Birmingham) In research to improve influenza therapies against H7N9 and other influenza strains, Chad Petit and his University of Alabama at Birmingham colleagues have detailed the binding site and mechanism of inhibition for two small-molecule experimental inhibitors of influenza viruses. Their report is published in the Journal of Biochemistry, (Source: EurekAlert! - Infectious and Emerging Diseases)
Source: EurekAlert! - Infectious and Emerging Diseases - November 2, 2018 Category: Infectious Diseases Source Type: news

Matter: How to Turbocharge Flu Protection (Llamas Required)
A giant antibody created in the laboratory shielded mice against dozens of flu strains, offering new hope against a winter misery. (Source: NYT Health)
Source: NYT Health - November 1, 2018 Category: Consumer Health News Authors: CARL ZIMMER Tags: Influenza Mice Vaccination and Immunization Antibodies Avian Influenza Immune System Viruses Epidemics Deaths (Fatalities) Genetic Engineering Science (Journal) Joost Kulkman Llamas Source Type: news

Matter: How to Turbocharge the Flu Shot (It Involves Llamas)
A giant antibody created in the laboratory shielded mice against dozens of flu strains, offering hope for better protection in humans. (Source: NYT Health)
Source: NYT Health - November 1, 2018 Category: Consumer Health News Authors: CARL ZIMMER Tags: Influenza Mice Vaccination and Immunization Antibodies Avian Influenza Immune System Viruses Epidemics Deaths (Fatalities) Genetic Engineering Science (Journal) Joost Kulkman Llamas Source Type: news

Matter: How to Turbocharge the Flu Shot
A giant antibody created in the laboratory protected mice against dozens of flu strains, offering hope for better protection in humans. (Source: NYT Health)
Source: NYT Health - November 1, 2018 Category: Consumer Health News Authors: CARL ZIMMER Tags: Influenza Mice Vaccination and Immunization Antibodies Avian Influenza Immune System Viruses Epidemics Deaths (Fatalities) Genetic Engineering Science (Journal) Joost Kulkman Llamas Source Type: news

Influenza: treatment and prophylaxis using anti-viral agents
This guidance covers definitions, treatment of suspected or confirmed influenza and post-exposure prophylaxis supply of zanamavir aqueous solution. Updates include a new summary algorithm for prescribing and the process for requesting zanamavir solution. It was updated in October 2018. (Source: Current Awareness Service for Health (CASH))
Source: Current Awareness Service for Health (CASH) - November 1, 2018 Category: Consumer Health News Source Type: news

New study to decode what makes people immune to influenza
(Human Vaccines Project) The key to lasting protection against influenza may be in your bones. The cells that naturally protect you against illness originate and live in your bone marrow -- and that is one spot where scientists are looking to understand the human immune system's response to influenza in a new study led by the Human Vaccines Project. The goal is to harness an understanding of the immune system to develop longer lasting protection against the flu. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - November 1, 2018 Category: International Medicine & Public Health Source Type: news

Monthly News Roundup - October 2018
FDA Approves Xofluza, a First-In-Class Flu Drug to Treat Symptoms It ’s been almost 20 years since a new influenza (flu) treatment was approved, and last year’s flu season was one of the deadliest in decades. In response, the U.S. Food and... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - October 31, 2018 Category: Pharmaceuticals Source Type: news

Practices should not worry over flu vaccines supply, GP leaders say
GP practices and patients should not be concerned over the supply of flu vaccines, which in some cases will be delivered later next month, GP leaders have said.  The BMA and the RCGP said that although there have been reports of patients being turned away from their practices because of limited stock, this has to do with the way the delivery of the adjuvanted trivalent influenza vaccine (a-TIV) had been arranged. Hide related content:  Show related contentread more (Source: Management in Practice)
Source: Management in Practice - October 31, 2018 Category: Practice Management Authors: vfiore Tags: *** Editor ' s Pick Patient Access Practice management Latest News Source Type: news

Vaccines – One size fits all... or does it? Examine the ABSURDITY of failed "vaccine logic"
(Natural News) Did you know that a pregnant woman, a 6-month-young child, and a 250 pound man all get the same dose of chemicals in any given inoculation, including the influenza vaccine? Whether the vaccine contains formaldehyde, aluminum, monosodium glutamate, squalene, sodium chloride, porcine gelatin, egg protein, E. coli, African Green Monkey kidney cells, neomycin,... (Source: NaturalNews.com)
Source: NaturalNews.com - October 30, 2018 Category: Consumer Health News Source Type: news

Low Levels of Flu Reported in U.S. From May to October
MONDAY, Oct. 29, 2018 -- From May 20 to Oct. 13, 2018, low levels of influenza activity were reported in the United States, according to a study published online Oct. 25 in Morbidity and Mortality Weekly Report. Eric J. Chow, M.D., from the U.S.... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - October 29, 2018 Category: Pharmaceuticals Source Type: news

Encourage Your Scleroderma Patients to Get Influenza Vaccine Encourage Your Scleroderma Patients to Get Influenza Vaccine
An important new study suggests that the adjuvant-free pandemic influenza A vaccine is safe and effective in patients with scleroderma.Rheumatology (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - October 29, 2018 Category: Consumer Health News Tags: Rheumatology Journal Article Source Type: news

Ask Well: Should I Get the High-Dose Flu Vaccine?
People younger than 65 can receive the high-dose vaccine, but there are caveats. (Source: NYT Health)
Source: NYT Health - October 26, 2018 Category: Consumer Health News Authors: RICHARD KLASCO, M.D. Tags: Vaccination and Immunization Labeling and Labels (Product) Influenza Elderly Source Type: news

FDA approves new drug to treat influenza
The U.S. Food and Drug Administration approved Xofluza (baloxavir marboxil) for the treatment of acute uncomplicated influenza (flu) in patients 12 years of age and older who have been symptomatic for no more than 48 hours. (Source: World Pharma News)
Source: World Pharma News - October 26, 2018 Category: Pharmaceuticals Tags: Featured FDA Regulatory Affairs Source Type: news

Abbott Introduces the Next Generation of Influenza A and B and Strep A Assays with Fastest-Ever Time to Molecular Results
NEW ASSAYS EMPOWER CLINICIANS TO MORE QUICKLY MAKE THE RIGHT DIAGNOSIS AT THE POINT-OF-CARE AND PRESCRIBE THE RIGHT TREATMENT ABBOTT PARK, Ill., Oct. 25, 2018 -- (Healthcare Sales & Marketing Network) -- Abbott (NYSE: ABT) announced today that the U.S.... Diagnostics, FDA, Product Launch Abbott, Influenza, Streptococcus, ID NOW (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - October 25, 2018 Category: Pharmaceuticals Source Type: news

Abbott Introduces the Next Generation of Influenza A & B and Strep A Assays with Fastest-Ever Time to Molecular Results
NEW ASSAYS EMPOWER CLINICIANS TO MORE QUICKLY MAKE THE RIGHT DIAGNOSIS AT THE POINT-OF-CARE AND PRESCRIBE THE RIGHT TREATMENT (Source: Abbott.com)
Source: Abbott.com - October 25, 2018 Category: Pharmaceuticals Source Type: news

Roche announces FDA approval of Xofluza (baloxavir marboxil) for influenza
Roche (SIX: RO, ROG; OTCQX: RHHBY) announced that the US Food and Drug Administration (FDA) has approved Xofluza™ (baloxavir marboxil) for the treatment of acute, uncomplicated influenza, or flu, in people 12 years of age and older. Xofluza is a first-in-class, single-dose oral medicine with a novel proposed mechanism of action that inhibits polymerase acidic endonuclease, an enzyme essential for viral replication. (Source: World Pharma News)
Source: World Pharma News - October 25, 2018 Category: Pharmaceuticals Tags: Featured Roche Business and Industry Source Type: news

Doctors promise 'flu vaccine is on its way'
BMA and RCGP move to reassure patients that adequate supplies will be available Related items fromOnMedica Influenza NHS seeks to ease concerns over flu jab availability Flu ‘jabathon’ aims to boost frontline staff vaccination rate More powerful flu jab available for over 65s this winter (Source: OnMedica Latest News)
Source: OnMedica Latest News - October 25, 2018 Category: UK Health Source Type: news

High-Dose Flu Vaccine More Effective for Patients on Dialysis High-Dose Flu Vaccine More Effective for Patients on Dialysis
Patients on dialysis who received a high-dose influenza vaccine were less likely to be hospitalized compared with those who received a standard-dose vaccine, a study found.Medscape Medical News (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - October 24, 2018 Category: Consumer Health News Tags: Nephrology News Source Type: news

FDA Approves New Drug To Treat The Flu
BOSTON (CBS) – On Wednesday, the FDA approved a new drug to treat the flu just in time for flu season. Xofluza is intended for the treatment of acute uncomplicated influenza in patients 12 and older. The prescription drug is given as a single oral dose. When taken within 48 hours of developing symptoms of the flu, Xofluza can help reduce the severity of symptoms and shorten the course of illness. While there are several other drugs on the market to treat people with early influenza, this is the first new flu treatment with a different mechanism of action approved in almost 20 years. That said, the best way to preve...
Source: WBZ-TV - Breaking News, Weather and Sports for Boston, Worcester and New Hampshire - October 24, 2018 Category: Consumer Health News Authors: Health – CBS Boston Tags: Boston News Health Syndicated Local Watch Listen Dr. Mallika Marshall influenza Xofluza Source Type: news

F.D.A. Approves New Drug for Flu
The new drug, sold as Xofluza, is about as effective as Tamiflu in shortening flu symptoms, and is expected to work against drug-resistant strains. (Source: NYT Health)
Source: NYT Health - October 24, 2018 Category: Consumer Health News Authors: DONALD G. McNEIL Jr. Tags: Influenza Drugs (Pharmaceuticals) Tamiflu (Drug) Gottlieb, Scott (1972- ) Genentech Inc Shionogi Xofluza Source Type: news

FDA OKs Xofluza, First New Flu Antiviral in Nearly 20 Years FDA OKs Xofluza, First New Flu Antiviral in Nearly 20 Years
Baloxavir marboxil is for the treatment of acute uncomplicated influenza in people age 12 years and older who have been symptomatic for no more than 48 hours.FDA Approvals (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - October 24, 2018 Category: Consumer Health News Tags: Infectious Diseases News Source Type: news

FDA Approves First New Influenza Drug in 20 Years
WEDNESDAY, Oct. 24, 2018 -- For the first time in nearly two decades, the U.S. Food and Drug Administration has approved a new type of antiviral influenza drug. The single oral dose of Xofluza (baloxavir marboxil) is for the treatment of... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - October 24, 2018 Category: Pharmaceuticals Source Type: news

The FDA Approved a New Flu Treatment, Just In Time for Flu Season
The Food and Drug Administration (FDA) has approved a new antiviral influenza treatment. The agency on Wednesday approved Genentech’s drug Xofluza, which can be taken via a single oral dose to help patients recover more quickly from the flu. It’s the “first new antiviral flu treatment with a novel mechanism of action approved by the FDA in nearly 20 years,” FDA Commissioner Dr. Scott Gottlieb said in a statement. The main factor differentiating Xofluza from other antiviral flu treatments on the market, such as Tamiflu and Relenza, is the way it’s taken. Xofluza is the only antiviral that can b...
Source: TIME: Health - October 24, 2018 Category: Consumer Health News Authors: Jamie Ducharme Tags: Uncategorized Drugs healthytime onetime Source Type: news

FDA Approves Xofluza (baloxavir marboxil) for the Treatment of Acute Uncomplicated Influenza
October 24, 2018 -- Today, the U.S. Food and Drug Administration approved Xofluza (baloxavir marboxil) for the treatment of acute uncomplicated influenza (flu) in patients 12 years of age and older who have been symptomatic for no more than 48... (Source: Drugs.com - New Drug Approvals)
Source: Drugs.com - New Drug Approvals - October 24, 2018 Category: Drugs & Pharmacology Source Type: news

Roche announces FDA approval of Xofluza (baloxavir marboxil) for influenza
Roche today announced that the US Food and Drug Administration (FDA) has approved Xofluza ™ (baloxavir marboxil) for the treatment of acute, uncomplicated influenza, or flu, in people 12 years of age and older. (Source: Roche Media News)
Source: Roche Media News - October 24, 2018 Category: Pharmaceuticals Source Type: news

Roche announces FDA approval of Xofluza (baloxavir marboxil) for influenza
Roche today announced that the US Food and Drug Administration (FDA) has approved Xofluza ™ (baloxavir marboxil) for the treatment of acute, uncomplicated influenza, or flu, in people 12 years of age and older. (Source: Roche Investor Update)
Source: Roche Investor Update - October 24, 2018 Category: Pharmaceuticals Source Type: news

FDA approves new drug to treat influenza
FDA approved Xofluza (baloxavir marboxil) to treat acute uncomplicated flu in patients 12 years old and older who have been symptomatic for less than 48 hours. (Source: Food and Drug Administration)
Source: Food and Drug Administration - October 24, 2018 Category: American Health Source Type: news

High-Dose Flu Vaccine May Cut Hospitalization in Dialysis Patients
WEDNESDAY, Oct. 23, 2018 -- Receipt of the high-dose influenza vaccine in 2016 to 2017 was associated with lower rates of hospitalization among dialysis patients, according to a study published online Oct. 23 in the Clinical Journal of the American... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - October 24, 2018 Category: Pharmaceuticals Source Type: news

Influenza and Tdap Vaccination Coverage Among Pregnant Women Influenza and Tdap Vaccination Coverage Among Pregnant Women
Did pregnant women adequately receive vaccination coverage for influenza and Tdap during the 2017-18 influenza season?Morbidity & Mortality Weekly Report (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - October 24, 2018 Category: Consumer Health News Tags: Ob/Gyn & Women ' s Health Journal Article Source Type: news

Fighting mutant influenza
(American Chemical Society) Another flu season is here, which means another chance for viruses to mutate. Already, most influenza A viruses contain a mutation that confers resistance against one class of antiviral medications, and the bugs are steadily gaining resistance against another class. Scientists report in ACS Medicinal Chemistry Letters a series of experiments designed to develop new medications that could potentially fight off the resistant and sensitive types of influenza A. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - October 24, 2018 Category: International Medicine & Public Health Source Type: news

Flu virus could evolve resistance to pandemic drug
(Imperial College London) The influenza virus can evolve resistance to an anti-flu drug currently in development for use in pandemics but only if there are multiple genetic mutations, a study has found. (Source: EurekAlert! - Infectious and Emerging Diseases)
Source: EurekAlert! - Infectious and Emerging Diseases - October 24, 2018 Category: Infectious Diseases Source Type: news

You are 550% more likely to get a respiratory infection if you receive the flu vaccine
(Natural News) Let’s assume for a moment that the flu vaccine provided a 100 percent guarantee against contracting influenza (which it doesn’t, but just pretend it does). Would it make sense to vaccinate your family against the flu if doing so meant you increased their risk of contracting other upper respiratory illnesses by more than... (Source: NaturalNews.com)
Source: NaturalNews.com - October 23, 2018 Category: Consumer Health News Source Type: news

Case Study: Influenza Turned Lethal
(MedPage Today) -- Fulminant myocarditis claims life of otherwise healthy child (Source: MedPage Today Cardiovascular)
Source: MedPage Today Cardiovascular - October 22, 2018 Category: Cardiology Source Type: news